Tick-Borne Diseases in Maine: Veterinary Guide for Dogs and Cats
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- The northward expansion of the blacklegged tick (Ixodes scapularis) in Maine is the primary driver for the increased prevalence of tick-borne diseases, including Lyme disease (Borrelia burgdorferi), anaplasmosis (Anaplasma phagocytophilum), and ehrlichiosis (Ehrlichia spp.).
- Lyme disease, caused by Borrelia burgdorferi, is the most common tick-borne illness in Maine dogs, presenting with lameness, fever, and lymphadenopathy; a severe, potentially fatal complication is Lyme nephritis.
- Diagnosis of anaplasmosis and ehrlichiosis relies on serological detection of antibodies and PCR testing on whole blood, with thrombocytopenia being a common hematologic finding.
- Treatment for these bacterial tick-borne diseases in dogs and cats primarily involves doxycycline (10 mg/kg PO q12-24h), with treatment durations varying from 14-30 days depending on the specific pathogen.
- Prevention strategies are critical and include the use of effective acaricides (e.g., isoxazolines, imidacloprid/flumethrin collars) and, for Lyme disease in dogs, vaccination against B. burgdorferi.
- A systematic diagnostic approach, starting with in-clinic ELISA for common pathogens and confirmed by quantitative C6 antibody assays or PCR, is essential for accurate diagnosis and effective management.
Introduction
Maine has experienced a significant emergence of tick-borne diseases over the past several decades, driven largely by the northward expansion and establishment of the blacklegged tick, Ixodes scapularis [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. This vector transmits multiple pathogens of veterinary importance, including Borrelia burgdorferi, Anaplasma phagocytophilum, and Babesia microti [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. Companion animals, particularly dogs and cats, are at substantial risk of exposure to these pathogens due to their peridomestic and outdoor activities [<a href="#ref-4">4</a>]. This article provides a clinical and diagnostic reference for veterinary professionals managing tick borne diseases in Maine, focusing on the primary bacterial pathogens affecting dogs and cats.
Tick Vectors in Maine
The primary tick species of veterinary concern in Maine include Ixodes scapularis (blacklegged tick), Dermacentor variabilis (American dog tick), and, with increasing frequency, Amblyomma americanum (lone star tick) [<a href="#ref-1">1</a>, <a href="#ref-4">4</a>, <a href="#ref-5">5</a>]. Ixodes scapularis is the principal vector for Borrelia burgdorferi, Anaplasma phagocytophilum, and Babesia microti [<a href="#ref-2">2</a>, <a href="#ref-3">3</a>]. Passive surveillance programs in Maine have documented the progressive inland spread of I. scapularis from coastal areas, advancing along major river valleys [<a href="#ref-1">1</a>, <a href="#ref-6">6</a>]. The distribution of D. variabilis has also expanded centrifugally from southwestern Maine [<a href="#ref-1">1</a>]. Amblyomma americanum, while not yet established in Maine, is repeatedly introduced via migratory birds and may become established in the future [<a href="#ref-5">5</a>].
The life cycle of I. scapularis is closely tied to environmental conditions. Overwinter survival of nymphs is facilitated by leaf litter and snowpack insulation, which buffer against low ambient temperatures [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>]. Microclimate conditions, including snow cover and leaf litter depth, significantly influence tick survival and distribution across climate gradients in Maine [<a href="#ref-7">7</a>, <a href="#ref-8">8</a>]. Small mammal hosts, particularly Peromyscus leucopus and Peromyscus maniculatus, serve as reservoirs for tick-borne pathogens and as hosts for immature tick stages [<a href="#ref-3">3</a>].
Lyme Disease (Borrelia burgdorferi)
Lyme disease is the most prevalent tick-borne disease in Maine and is caused by the spirochete Borrelia burgdorferi [<a href="#ref-2">2</a>, <a href="#ref-6">6</a>]. The pathogen is transmitted primarily by nymphal and adult I. scapularis [<a href="#ref-2">2</a>]. In dogs, clinical signs of Lyme disease include acute lameness, fever, lymphadenopathy, and lethargy [<a href="#ref-9">9</a>]. A subset of infected dogs develops Lyme nephritis, a severe immune-mediated glomerulonephritis that can be fatal. Cats are less commonly diagnosed with clinical Lyme disease, but seropositivity has been documented in endemic areas.
The prevalence of B. burgdorferi in I. scapularis nymphs in Maine has been reported to range from 19% to 25% during the period 2017 to 2021, while adult tick prevalence ranges from 49% to 54% [<a href="#ref-2">2</a>]. These infection rates have increased over time, contributing to a rising entomological risk [<a href="#ref-2">2</a>]. The incidence of Lyme disease in Maine is correlated with I. scapularis submission rates in the northern tier of the state, though a decoupling of tick abundance and disease incidence has been observed in the southern tier, where tick populations are well established [<a href="#ref-6">6</a>].
Diagnosis of Lyme disease in dogs relies on serological detection of antibodies against B. burgdorferi, typically using commercial ELISA kits that detect antibodies to the C6 peptide [<a href="#ref-9">9</a>]. Quantitative C6 antibody assays can help differentiate exposure from active infection and monitor response to therapy. Polymerase chain reaction (PCR) assays on blood or synovial fluid can detect spirochetal DNA, though sensitivity is variable due to the transient nature of bacteremia [<a href="#ref-9">9</a>].
Treatment of canine Lyme disease involves a course of doxycycline (10 mg/kg orally every 12 to 24 hours for 30 days) or amoxicillin (20 mg/kg orally every 8 hours for 30 days) [<a href="#ref-9">9</a>]. Clinical improvement is typically observed within 24 to 48 hours of initiating therapy. For dogs with Lyme nephritis, aggressive immunosuppressive therapy and supportive care are required, and the prognosis is guarded.
Prevention of Lyme disease in dogs includes the use of acaricides to reduce tick attachment and vaccination against B. burgdorferi [<a href="#ref-10">10</a>]. Several commercially available bacterin-based vaccines are available for dogs, though their efficacy is not absolute, and they should be used in conjunction with tick control measures [<a href="#ref-10">10</a>]. Tick prevention for dogs and cats is a critical component of integrated management strategies.
Anaplasmosis (Anaplasma phagocytophilum)
Anaplasmosis, caused by the obligate intracellular bacterium Anaplasma phagocytophilum, is another important tick-borne disease in Maine [<a href="#ref-2">2</a>, <a href="#ref-11">11</a>]. The pathogen is transmitted by I. scapularis and infects granulocytes, primarily neutrophils [<a href="#ref-2">2</a>]. In dogs, clinical signs include fever, lethargy, anorexia, lameness, and thrombocytopenia. Neurologic signs, such as ataxia and seizures, have been reported in some cases. Cats infected with A. phagocytophilum may present with fever, lethargy, and anorexia, though clinical disease appears less common than in dogs.
The prevalence of A. phagocytophilum in I. scapularis in Maine has been estimated at 4% to 6% in nymphs and 4% to 9% in adults for the period 2017 to 2021 [<a href="#ref-2">2</a>]. These rates have increased over time, mirroring trends observed for B. burgdorferi [<a href="#ref-2">2</a>]. In a study of eastern moose (Alces alces americana) in Maine, over half of the sampled animals were infected with Anaplasma spp., though the strain identified was divergent from A. phagocytophilum and was not associated with winter ticks (Dermacentor albipictus) [<a href="#ref-11">11</a>].
Diagnosis of anaplasmosis in dogs and cats is based on serological detection of antibodies to A. phagocytophilum using commercial ELISA kits or immunofluorescence assays. PCR testing on whole blood is highly sensitive and specific for detecting active infection during the acute phase [<a href="#ref-11">11</a>]. Hematologic abnormalities, particularly thrombocytopenia and mild anemia, are common findings on complete blood counts.
Treatment of anaplasmosis involves doxycycline (10 mg/kg orally every 12 to 24 hours for 14 to 28 days). Clinical improvement is usually rapid, often within 24 to 48 hours. No vaccine is currently available for anaplasmosis in dogs or cats. Prevention relies on rigorous tick control.
Ehrlichiosis (Ehrlichia spp.)
Ehrlichiosis in dogs is caused primarily by Ehrlichia canis, transmitted by Rhipicephalus sanguineus (brown dog tick), and Ehrlichia ewingii, transmitted by Amblyomma americanum (lone star tick) [<a href="#ref-5">5</a>]. In Maine, E. canis is less common due to the limited distribution of R. sanguineus in the state, but E. ewingii may become more relevant as A. americanum expands its range [<a href="#ref-5">5</a>]. Ehrlichia chaffeensis, the agent of human monocytic ehrlichiosis, can also infect dogs.
Clinical signs of ehrlichiosis in dogs include fever, lethargy, anorexia, lymphadenomegaly, and thrombocytopenia. In chronic E. canis infection, pancytopenia, epistaxis, and bleeding diatheses may develop. Cats are susceptible to Ehrlichia spp. infection, though clinical disease is poorly characterized.
Diagnosis is achieved through serology (ELISA or immunofluorescence) and PCR. Hematologic findings often include thrombocytopenia, which may be severe. Treatment with doxycycline (10 mg/kg orally every 12 to 24 hours for 28 days) is standard. For E. canis, a longer course of therapy may be required.
Diagnostic Approaches
A systematic diagnostic approach is essential for managing tick-borne diseases in dogs and cats in Maine. The following decision tree outlines a clinical workflow for a patient presenting with signs suggestive of tick-borne illness.
graph TD
A["Patient presents with fever, lethargy, lameness, or thrombocytopenia"] --> B{"History of tick exposure in Maine?"};
B -->|"Yes"| C["Perform in-clinic ELISA for B. burgdorferi, A. phagocytophilum, and Ehrlichia spp."];
B -->|"No"| D["Consider other differential diagnoses"];
C -->|"Positive for B. burgdorferi"| E["Confirm with quantitative C6 antibody assay or PCR"];
C -->|"Positive for A. phagocytophilum"| F["Confirm with PCR on whole blood"];
C -->|"Positive for Ehrlichia spp."| G["Confirm with PCR and consider geographic origin"];
C -->|"Negative"| H["Consider PCR panel for tick-borne pathogens if clinical suspicion remains high"];
E --> I["Initiate doxycycline therapy and monitor renal function"];
F --> I;
G --> I;
H --> J["Evaluate for other causes: immune-mediated disease, neoplasia, other infections"];
I --> K["Recheck clinical status and hematology in 48-72 hours"];
K -->|"Improvement"| L["Complete antibiotic course and continue tick prevention"];
K -->|"No improvement"| M["Re-evaluate diagnosis and consider co-infections or alternative diagnoses"];Serological testing using commercial ELISA kits is the first-line diagnostic tool for detecting antibodies to B. burgdorferi, A. phagocytophilum, and Ehrlichia spp. in dogs. These assays are widely available and provide rapid results. However, serology cannot distinguish active infection from past exposure. PCR testing on whole blood or tissue samples provides confirmation of active infection and is particularly useful in acute cases where seroconversion has not yet occurred [<a href="#ref-3">3</a>, <a href="#ref-11">11</a>]. Automated impedance analyzers are used for complete blood counts to detect thrombocytopenia, anemia, and leukocyte abnormalities.
Treatment Protocols
The cornerstone of treatment for bacterial tick-borne diseases in dogs and cats is doxycycline. The recommended dosage is 10 mg/kg orally every 12 to 24 hours. The duration of therapy varies by pathogen: 30 days for Lyme disease, 14 to 28 days for anaplasmosis, and 28 days for ehrlichiosis. For animals that cannot tolerate doxycycline, amoxicillin (20 mg/kg orally every 8 hours) may be used for Lyme disease, though it is less effective against Anaplasma and Ehrlichia spp. Supportive care, including fluid therapy and antiemetics, may be indicated in severe cases.
Prevention and Tick Control
Prevention of tick-borne diseases in dogs and cats in Maine requires an integrated approach combining environmental management, host-targeted acaricides, and vaccination where available. Acaricides applied topically or orally are highly effective at reducing tick attachment and feeding. Products containing isoxazolines (e.g., afoxolaner, fluralaner, sarolaner) provide rapid tick kill and sustained protection. Tick collars containing imidacloprid and flumethrin are also effective.
Environmental tick control includes habitat modification such as leaf litter removal, which reduces nymphal overwintering survival [<a href="#ref-8">8</a>]. Deer herd reduction on offshore islands in Maine has been shown to lower I. scapularis density and Lyme disease risk [<a href="#ref-12">12</a>]. Integrated tick management (ITM) strategies that combine multiple control methods are recommended for long-term suppression of tick populations [<a href="#ref-12">12</a>].
Vaccination against B. burgdorferi is available for dogs and is recommended for animals living in or traveling to endemic areas of Maine [<a href="#ref-10">10</a>]. Vaccination does not eliminate the need for tick control but provides an additional layer of protection. No vaccines are currently available for anaplasmosis or ehrlichiosis in dogs or cats.
Conclusion
Tick-borne diseases in Maine represent a significant and growing threat to the health of dogs and cats. The primary bacterial pathogens, Borrelia burgdorferi, Anaplasma phagocytophilum, and Ehrlichia spp., are transmitted by Ixodes scapularis and other tick vectors that are expanding their range within the state [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>, <a href="#ref-5">5</a>]. Veterinary professionals must maintain a high index of suspicion for these diseases in patients presenting with compatible clinical signs and a history of tick exposure. Accurate diagnosis relies on a combination of serology, PCR, and hematologic evaluation. Treatment with doxycycline is effective for most bacterial tick-borne infections, and prevention through rigorous tick control and vaccination is essential for reducing disease incidence.